Mobile

A Study to Evaluate how Safe and the Body's ability to Tolerate PF-03715455 when Given Twice Daily for 4 Weeks to Subjects with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Update Il y a 4 ans
Reference: U1111-1156-7217

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine the effect, at week 4, of orally inhaled PF-03715455 680 micrograms BID on trough FEV1 in subjects with moderate to severe COPD on a stable regimen of short or long acting bronchodilators.

Inclusion criteria

  • Chronic Obstructive Pulmonary Disease (COPD)

Links